Dar Zavain 4
4 · RECURSION PHARMACEUTICALS, INC. · Filed Jul 6, 2023
Insider Transaction Report
Form 4
Dar Zavain
Director
Transactions
- Award
Class A Common Stock
2023-07-03+1,863→ 72,044 total
Footnotes (1)
- [F1]The shares were issued pursuant to the Issuer's Outside Director Compensation Policy